GSK ready to defend claims at state level after federal judge dismisses Zantac suits

Dec. 07, 2022 4:51 AM ETSanofi (SNY), GSKPFE, RDY, TEVA, PRGO, HLNBy: Ravikash, SA News Editor1 Comment

Shipments Of A Generic Zantac Halted After FDA Warns Of Low Level Probable Carcinogen In Zantac And Its Generic Version

Drew Angerer

GSK (NYSE:GSK) issued a statement on Wednesday after a federal judge in Florida ruled that the company and Sanofi (NASDAQ:SNY) would not have to face thousands of lawsuits related to claims that

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.